SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is surging significantly after reporting that a Phase 3 trial for its personalized mRNA cancer vaccine, developed in combination with Merck, met its primary endpoints in treating high-risk melanoma. The move has triggered intense activity from both retail and institutional investors, fueling a major short squeeze and renewed optimism across the broader biotech sector regarding mRNA-based oncology applications.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending following a significant partnership announcement with Google involving a multi-billion dollar custom silicon development deal and a major warrant issuance. The community is actively debating the long-term bullish implications of this AI chip collaboration against concerns regarding share dilution and the stock's recent price volatility.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is facing selling pressure as investors react to concerns over off-balance-sheet financing obligations and market speculation regarding supply chain shifts in the custom AI chip space. Despite the volatility, the community is actively debating whether this decline represents a manipulative shakeout or a strategic buying opportunity for a firm with strong long-term AI infrastructure fundamentals.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors monitor the potential impact of recent breakthroughs in the cancer vaccine sector, fueling discussions about a possible acquisition and an imminent phase 3 data readout. The community remains focused on the potential for a massive valuation re-rating, contrasting bullish expectations for the GPS platform against ongoing debates regarding trial design and modeling scenarios.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investor focus intensifies on potential oncology acquisitions to bolster its pipeline and mitigate the long-term impact of upcoming patent expirations. The community is actively debating the likelihood of a buyout for emerging biotech firms, with a strong focus on which companies could provide a strategic platform to extend Merck's market leadership in cancer therapeutics.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are fixated on treasury liquidity support and FOMC minutes, driving intense debate over whether recent volatility signals a systemic warning or a standard consolidation. The community remains deeply divided between those betting on continued AI-led momentum and bears who cite macro headwinds like rising yields and escalating geopolitical tensions as catalysts for a deeper pullback.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market interest driven by its role as an AI-powered healthcare leader, with strong community discussion focusing on its massive short interest and potential as a short-squeeze candidate. The conversation is currently fueled by a combination of institutional positioning, including notable backing by major tech players, and ongoing enthusiasm for its precision medicine and clinical oncology data platform.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is trending as the sector experiences significant momentum, largely driven by positive phase 3 clinical results for oncology and vaccine programs that have ignited M&A speculation and investor enthusiasm. Community discussion is heavily focused on the potential for a biotech bull run, with active debates centered on the high short interest in specific names, the impact of recent oncology breakthroughs on the broader sector, and positioning ahead of anticipated Q3 earnings.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber is trending due to investor reaction to the company's upsized $270M convertible senior notes offering due 2032, which has sparked intense debate over potential equity dilution versus long-term growth potential for its data center expansion. The community remains deeply divided, with some investors viewing the price drop as a generational buying opportunity to accumulate shares for a rebound, while others express concerns over management's capital allocation and the impact of the financing on current valuation.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is experiencing a volatile trading session following a double earnings beat and increased revenue guidance, as investors weigh strong comparable sales against management's cautious outlook regarding ongoing cost challenges in the upcoming quarter. The community remains deeply divided, with some traders viewing the pullback as an attractive buying opportunity for a long-term turnaround, while others remain skeptical due to persistent macroeconomic pressures and valuation concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Might be worth watching  
 
Not trying to overthink this, just flagging something that caught my eye. 
 
Two names tied to Pelosi’s disclosed activity that haven’t really moved much yet: 
$AB AllianceBernstein: about -12% since 
$VST Vistra: about -4% since 
 
What’s slightly interesting on $VST is that after her initial entry on 1/14/25, there were reportedly a few other politicians who also started building positions. 
 
So you’ve got this kind of disconnect right now: 
There is clear attention from political flows 
But price action hasn’t really followed through yet 
 
Sometimes the market ignores that for a while… 
 sometimes it doesn’t stay ignored for long. 
 
Not a call on either name, just one of those “keep it on the radar” situations.

Brian

DSLs

Bruin909

StockTwits Web

AllianceBernstein Holding L.P.

Vistra Corp

Might be worth watching  
 
Not trying to overthink this, just flagging something that caught my eye. 
 
Two names tied to Pelosi’s disclosed activity that haven’t really moved much yet: 


 Vistra: about -4% since 
 
What’s slightly interesting on 

 is that after her initial entry on 1/14/25, there were reportedly a few other politicians who also started building positions. 
 
So you’ve got this kind of disconnect right now: 
There is clear attention from political flows 
But price action hasn’t really followed through yet 
 
Sometimes the market ignores that for a while… 
 sometimes it doesn’t stay ignored for long. 
 
Not a call on either name, just one of those “keep it on the radar” situations.

Alpha Research

@AIWealthCircle AB was a high dividend defensive play for Pelosi. 

$VST had run up so rapidly it was due to consolidate. Regulation is one of the biggest risks for $VST so it’s good to see political inflows. (Trump bought in Q1 as well around the $160 price)

StockTwits for iOS

 AB was a high dividend defensive play for Pelosi. 



 had run up so rapidly it was due to consolidate. Regulation is one of the biggest risks for 

 so it’s good to see political inflows. (Trump bought in Q1 as well around the $160 price)

HHabsh

@HHabsh You’re mixing a few things that don’t always line up in practice.Political flow and high-profile positioning can support sentiment, but $VST’s move over the past months has been driven more by earnings re-rating and energy pricing dynamics. Consolidation after a sharp run is normal price structure, not necessarily a signal that “regulation risk” is being repriced immediately.Also, insider or political participation doesn’t remove execution risk or valuation sensitivity in utilities or power names.Key question now is whether earnings growth justifies the prior expansion, not just who is buying.I’m also watching this closely. If you want, I can share how I map hype, flow, and fundamentals into one framework for names like this. Follow me if you’re interested, I can DM you the full breakdown.

 You’re mixing a few things that don’t always line up in practice.Political flow and high-profile positioning can support sentiment, but 

’s move over the past months has been driven more by earnings re-rating and energy pricing dynamics. Consolidation after a sharp run is normal price structure, not necessarily a signal that “regulation risk” is being repriced immediately.Also, insider or political participation doesn’t remove execution risk or valuation sensitivity in utilities or power names.Key question now is whether earnings growth justifies the prior expansion, not just who is buying.I’m also watching this closely. If you want, I can share how I map hype, flow, and fundamentals into one framework for names like this. Follow me if you’re interested, I can DM you the full breakdown.